Monoclonal Antibodies Prevent HIV in Proof-of-Concept Trial

An experimental monoclonal antibody drug effectively prevented 75% of infections from HIV-1 isolates sensitive to that antibody in phase 2b trials of more than 4500 people across three continents, according to a study published March 18 in the New England Journal of Medicine. Although the drug, VRC01, reduced the incidence of HIV-1 cases from VRC01-sensitive isolates, it did not significantly reduce overall […]
Continue reading »